Matches in SemOpenAlex for { <https://semopenalex.org/work/W1496233721> ?p ?o ?g. }
- W1496233721 endingPage "88" @default.
- W1496233721 startingPage "82" @default.
- W1496233721 abstract "Abstract Objective: To assess the effect of medication on neurological abnormalities in patients with bipolar affective disorder. Patients and Methods: Neurological abnormalities were examined in 30 drug-free patients and 30 drug-treated patients meeting Diagnostic and Statistical Manual of Mental Disorders, 4th edition diagnostic criteria for bipolar affective disorder, and 20 age- and sex-matched controls, using the Extended Standard Neurological Assessment Instrument. Mania and depression were assessed using the Young Mania Rating Scale and the Hamilton Rating Scale for Depression, respectively. Side effects of medications were assessed using the Udvalg for Kliniske Undersogelser Side Effect Rating Scale. Results: Patients with bipolar affective disorder had higher mean total scores on the Extended Standard Neurological Assessment Instrument (drug-free group 22.83 [+ or -] 11.04, drug-treated group 22.00 [+ or -] 10.23) than controls, who did not score on any items of the neurological battery. There was a significant excess of hard signs and involuntary movements in the drug-treated group compared with the drug-free group, and a significant positive correlation between hard signs and the involuntary movements score and the neurological subscore on Udvalg for Kliniske Undersogelser Side Effect Rating Scale in the drug-treated group. Conclusion: The presence of neurological signs in drug-free patients with bipolar affective disorder suggests that neurological abnormalities may occur independently of medication effects. Side effects of drug treatment for bipolar affective disorder may contribute to the prevalence of neurological abnormalities in this patient population. Key words: Bipolar disorder, Dyskinesia, drug-induced, Neurologic manifestations Introduction There has been a steady increase in interest and appreciation of the biological underpinnings of mood disorders. Bipolar disorder appears to be related to anatomic abnormalities in the medial temporal lobe, in particular the amygdala, prefrontal cortex and cerebellum. (1) Recent magnetic resonance imaging findings support a neurodevelopmental etiology for bipolar affective disorder, at least in a subgroup of patients, as for schizophrenia. The frequency of medial temporal lobe (hippocampus/amygdala complex) hypoplasia noted in patients with bipolar affective disorder was similar to that seen in schizophrenia, and correlated with the degree of cognitive impairment. (2) A meta-analysis by Videbech (3) showed an increased ventricle/brain ratio and other signs of cerebral atrophy, as well as an increased frequency of signal hyperintensity, in the frontal lobes and basal ganglia of patients with bipolar affective disorder. Shioiri et al (4) reported a higher incidence of cavum septum pellucidum in subjects with bipolar affective disorder than controls, but lower than in subjects with schizophrenia. Neurological soft signs (NSS) have been reported in minimal brain dysfunction, (5) emotionally unstable character, (6) heavy polydrug users, (7) borderline personality disorder, (8) obsessive compulsive disorder, (9) and consistently in individuals with schizophrenia. (10,11) Nasrallah et al (12) found that NSS are as common in individuals with mania as in those with schizophrenia. An excess of neurological signs in adults with bipolar affective disorder has also been reported by other researchers. (13-15) Basu et al (16) reported similar findings in adolescents with mania. These soft signs are thought to reflect diffuse brain dysfunction. However, it has been suggested that although diffuse, NSS may reflect selective dysfunction in areas of motor coordination, integrative sensory function, and complex motor task coordination. (17) One area of interest has been the role of medication in the expression of neurological abnormalities. Although few studies have been able to exclude the influence of medication in the appearance of neurological abnormalities, (6,18) a comprehensive review by Heinrichs and Buchanan (17) concluded that medications do not seem to alter neurological signs in most cases of schizophrenia. …" @default.
- W1496233721 created "2016-06-24" @default.
- W1496233721 creator A5027405787 @default.
- W1496233721 creator A5072741745 @default.
- W1496233721 creator A5075390981 @default.
- W1496233721 date "2005-09-01" @default.
- W1496233721 modified "2023-10-02" @default.
- W1496233721 title "Neurological abnormalities in drug-free and drug-treated patients with bipolar affective disorder" @default.
- W1496233721 cites W127955425 @default.
- W1496233721 cites W1506614674 @default.
- W1496233721 cites W1568429456 @default.
- W1496233721 cites W1969552236 @default.
- W1496233721 cites W1983055116 @default.
- W1496233721 cites W1992216152 @default.
- W1496233721 cites W2005405100 @default.
- W1496233721 cites W2015738153 @default.
- W1496233721 cites W2016521877 @default.
- W1496233721 cites W2021404482 @default.
- W1496233721 cites W2022674975 @default.
- W1496233721 cites W2045102838 @default.
- W1496233721 cites W2050372098 @default.
- W1496233721 cites W2059450281 @default.
- W1496233721 cites W2060099042 @default.
- W1496233721 cites W2067982083 @default.
- W1496233721 cites W2077290107 @default.
- W1496233721 cites W2082916787 @default.
- W1496233721 cites W2090447468 @default.
- W1496233721 cites W2098644261 @default.
- W1496233721 cites W2102006409 @default.
- W1496233721 cites W2109497573 @default.
- W1496233721 cites W2114613490 @default.
- W1496233721 cites W2116685565 @default.
- W1496233721 cites W2126648063 @default.
- W1496233721 cites W2132343770 @default.
- W1496233721 cites W2132906677 @default.
- W1496233721 cites W2147865543 @default.
- W1496233721 cites W2167659819 @default.
- W1496233721 cites W2335471937 @default.
- W1496233721 cites W2405382910 @default.
- W1496233721 cites W2407364351 @default.
- W1496233721 cites W2409358136 @default.
- W1496233721 cites W2415958435 @default.
- W1496233721 cites W2423578071 @default.
- W1496233721 cites W298197462 @default.
- W1496233721 cites W5841390 @default.
- W1496233721 cites W74267703 @default.
- W1496233721 hasPublicationYear "2005" @default.
- W1496233721 type Work @default.
- W1496233721 sameAs 1496233721 @default.
- W1496233721 citedByCount "1" @default.
- W1496233721 crossrefType "journal-article" @default.
- W1496233721 hasAuthorship W1496233721A5027405787 @default.
- W1496233721 hasAuthorship W1496233721A5072741745 @default.
- W1496233721 hasAuthorship W1496233721A5075390981 @default.
- W1496233721 hasConcept C118552586 @default.
- W1496233721 hasConcept C126322002 @default.
- W1496233721 hasConcept C138496976 @default.
- W1496233721 hasConcept C139719470 @default.
- W1496233721 hasConcept C15744967 @default.
- W1496233721 hasConcept C162324750 @default.
- W1496233721 hasConcept C187212893 @default.
- W1496233721 hasConcept C2776174506 @default.
- W1496233721 hasConcept C2776466505 @default.
- W1496233721 hasConcept C2776809841 @default.
- W1496233721 hasConcept C2776867660 @default.
- W1496233721 hasConcept C2777089681 @default.
- W1496233721 hasConcept C2780051608 @default.
- W1496233721 hasConcept C2780733359 @default.
- W1496233721 hasConcept C2908647359 @default.
- W1496233721 hasConcept C71924100 @default.
- W1496233721 hasConcept C83849319 @default.
- W1496233721 hasConcept C99454951 @default.
- W1496233721 hasConceptScore W1496233721C118552586 @default.
- W1496233721 hasConceptScore W1496233721C126322002 @default.
- W1496233721 hasConceptScore W1496233721C138496976 @default.
- W1496233721 hasConceptScore W1496233721C139719470 @default.
- W1496233721 hasConceptScore W1496233721C15744967 @default.
- W1496233721 hasConceptScore W1496233721C162324750 @default.
- W1496233721 hasConceptScore W1496233721C187212893 @default.
- W1496233721 hasConceptScore W1496233721C2776174506 @default.
- W1496233721 hasConceptScore W1496233721C2776466505 @default.
- W1496233721 hasConceptScore W1496233721C2776809841 @default.
- W1496233721 hasConceptScore W1496233721C2776867660 @default.
- W1496233721 hasConceptScore W1496233721C2777089681 @default.
- W1496233721 hasConceptScore W1496233721C2780051608 @default.
- W1496233721 hasConceptScore W1496233721C2780733359 @default.
- W1496233721 hasConceptScore W1496233721C2908647359 @default.
- W1496233721 hasConceptScore W1496233721C71924100 @default.
- W1496233721 hasConceptScore W1496233721C83849319 @default.
- W1496233721 hasConceptScore W1496233721C99454951 @default.
- W1496233721 hasIssue "3" @default.
- W1496233721 hasLocation W14962337211 @default.
- W1496233721 hasOpenAccess W1496233721 @default.
- W1496233721 hasPrimaryLocation W14962337211 @default.
- W1496233721 hasRelatedWork W1970902032 @default.
- W1496233721 hasRelatedWork W1982092707 @default.
- W1496233721 hasRelatedWork W1987494895 @default.
- W1496233721 hasRelatedWork W2006124435 @default.